Skip to main content
Clinical Trials/RBR-7ncggq
RBR-7ncggq
Recruiting
未知

Postoperative Pain analysis with perioperative administration of Pregabalin in patients submitted to Knee Arthroscopy

Hospital São Domingos0 sitesMay 30, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Hospital São Domingos
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with chronic knee instability; patients older than 18 years; physical status classification according to the scale of the American Society of Anesthesiologists (ASA) I and II;
  • without local and systemic inflammatory diseases; isolated lesions of the anterior cruciate ligament (no other knee ligaments);
  • no history of fractures in the knee region;
  • absence of previous surgeries in the knee region; operated by the orthopedist of the team;
  • ability to read, understand and agree to the inclusion of your data
  • in this research.

Exclusion Criteria

  • Skeletally immature patients; chondral lesions greater than 2 cm2; associated surgical procedures, such as osteotomies, and other knee ligaments; neurological, muscular, rheumatologic, neoplastic or infectious diseases that could provoke some type of joint involvement (gout, multiple myeloma,
  • psoriasis, lymphoma, Paget's disease, rheumatoid arthritis, chronic renal failure,
  • osteomyelitis, ankylosing spondylitis, systemic lupus erythematosus); patients without clinical conditions, hypertensive, with coagulopathies, pregnant women; chronic use of anticoagulants; use of analgesics up to 24 h before the surgical procedure; patients who refused to sign the EHIC; patients not operated at the São Domingos Hospital; refusal or impossibility of the patient to perform the postoperative rehabilitation; non\-acceptance of the anesthesiologist in following the protocol of the project; patients allergic to the medications used in the protocol; patients who declared themselves indigenous.

Outcomes

Primary Outcomes

Not specified

Similar Trials